Navigation Links
Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
Date:5/15/2009

STOCKHOLM, Sweden, May 15 /PRNewswire-USNewswire/ -- The Karolinska Institutet in Stockholm today awarded an honorary post-doctoral degree to Kevin J. Tracey, MD, director and chief executive officer of The Feinstein Institute for Medical Research in Manhasset, NY.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090515/DC17878)

Dr. Tracey, a neurosurgeon whose work has helped unravel how the brain communicates with the immune system, joins a long and distinguished list of scientists who have received this honor from the Karolinska Institutet, including Nobel Prize winners Paul Greengard, PhD, and Torsten Weisel, PhD, both at Rockefeller University in Manhattan.

Each year, the Karolinska Institutet awards three honorary degrees to scientists selected by the Karolinska's Board of Research. Others honored today by the Karolinska at Stockholm City Hall were Hakan Mogren, one of Sweden's most prominent figures within trade and industry, and Ulla Fohrer, a speech therapist and researcher at Karolinska Institutet. The three honorees received their doctoral hats, diplomas and rings from the Dean of Research as confirmation of their new status.

Dr. Tracey's discoveries have paved the way for the development of new medicines to treat chronic rheumatoid arthritis, inflammatory bowel disease and infection. He has made considerable contributions towards improving knowledge of regulating inflammatory processes.

The Karolinska Institutet is one of the leading medical universities in Europe. Through research and education, the Karolinska Institutet contributes to improving human health. Each year, the Nobel Assembly at the Karolinska Institutet awards the Nobel Prize in Physiology or Medicine.

In 2008, the Karolinska Institutet and the Feinstein Institute signed a collaborative agreement that paves the way for Karolinska graduates to conduct post-doctoral research in New York and scientists from the Feinstein to study at the Karolinska's laboratories in Stockholm.

About The Feinstein Institute for Medical Research: Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in cancer, leukemia, lymphoma, Parkinson's disease, Alzheimer's disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, inflammatory bowel disease, diabetes, human genetics, neuroimmunology, and medicinal chemistry. Feinstein researchers are developing new drugs and drug targets, and producing results where science meets the patient, annually enrolling some 10,000 subjects into clinical research programs.


'/>"/>
SOURCE The Feinstein Institute for Medical Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Karolinska Development Invests in EvoStem Finland Oy
2. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
3. The Feinstein to collaborate with Swedens Karolinska Institute
4. 3 new honorary doctors at Karolinska Institutet
5. Karolinska Institutets Pedersen to receive GSAs 2007 Distinguished Career Award
6. YWCA USA 2009 Hallmark Initiative Awards Presented to YWCA Central Massachusetts and YWCA Niagara
7. Eleventh Annual Welcome Back Awards Program Honors Individuals who Positively Impact the Depression Community
8. SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards
9. ScienceFirst Receives ADCNJ Awards
10. ADA Foundation Hosts Second Give Kids A Smile Awards Gala
11. HealthWorldNet.com Announces HealthWiNs Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today ... Inc.,s Supplier Horizon Award . One ... Guerbet was recognized for its support of Premier members ... through clinical excellence, and commitment to lower costs. ... receive this recognition of our outstanding customer service from ...
Breaking Medicine Technology: